Asthma Treatment Medical Course
For Educational Use Only - Fair Use - See a new technique to treat severe asthma. rn....
- published: 17 Dec 2013
- views: 183
- author: Abiasaph Abiathar
More than one million people receiving treatment for asthma may have been misdiagnosed, according to a health watchdog. The National Institute for Health and Care Excellence (NICE) said studies showed up to 30% of the 4.1m people treated...
Belfast Telegraph 2015-01-28More than a million adults in the UK may be wrongly diagnosed as asthmatic and be receiving unnecessary medication as a result, warns an NHS watchdog. NICE says a third of...
BBC News 2015-01-28Medicines watchdog says up to 30% of the 4.1m people treated for asthma in UK show no ‘clear evidence’ of having condition ...
The Guardian 2015-01-28Arnuity(TM) Ellipta(R) is now available in the US for once-daily maintenance treatment of asthma. Arnuity Ellipta is available in two approved doses, 100mcg and 200mcg....
PR Newswire 2015-01-26Like World News?
...
The Daily Telegraph 2015-01-28In this cold weather it is vital that the one in 11 people with asthma in your area is prepared. Data shows there is a peak in asthma deaths every January in England and Wales. Yet, people with asthma have told us they have thought twice about going to hospital or their GP in the last four weeks in spite of knowing they needed specialist treatment. We want to reassure your...
Belfast Telegraph 2015-01-27DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jvn2s8/global_asthma) has announced the addition of the "Global Asthma Epidemiology...
Business Wire 2015-01-26We would be better served by a more informed understanding of gains to be expected by taking a drug In his State of the Union address last week, President Obama encouraged the development of “precision medicine,” which would tailor treatments based on individuals’ genetics or physiology. This is an effort to improve medical care’s effectiveness, which might cause some to...
Deccan Herald 2015-01-27Allegheny Health Network Study Raises Concerns About OTC Availability of Common Treatment for Allergy Symptoms PITTSBURGH, Pa (PRWEB) January 26, 2015 An Allegheny Health Network clinical trial examining whether intranasal corticosteroids stunt children’s growth – the first such trial conducted in accordance with U.S. Food and Drug Administration guidelines - found a small but...
Seattle Post 2015-01-27WASHINGTON, Jan. 27, 2015 /PRNewswire-USNewswire/ -- A novel study by the Asthma and Allergy Foundation of America (AAFA) finds significant differences among physician groups in knowledge and attitudes regarding anaphylaxis. In a Letter to the Editor published recently in the Journal of Allergy and Clinical Immunology (JACI), the authors of the study summarized results from the...
PR Newswire 2015-01-27Jan 26, 2015, 11:20am CST Send this to a friend Thank you for sharing. Your email has been sent. Email address of friend (insert comma between multiple addresses): Your email address: Copy Me Add a brief note: Send Email Sending Close UTHSC Dr. Rennolds Ostrom has received more than $1 million in funds from the National Institutes of Health for asthma research. Senior Staff...
The Business Review 2015-01-26Asthma (from the Greek άσθμα, ásthma, "panting") is the common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Asthma is clinically classified according to the frequency of symptoms, forced expiratory volume in 1 second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic).
It is thought to be caused by a combination of genetic and environmental factors. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol). Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by inhaling corticosteroids.Leukotriene antagonists are less effective than corticosteroids and thus less preferred.
Its diagnosis is usually made based on the pattern of symptoms and/or response to therapy over time. The prevalence of asthma has increased significantly since the 1970s. As of 2010, 300 million people were affected worldwide. In 2009 asthma caused 250,000 deaths globally. Despite this, with proper control of asthma with step down therapy, prognosis is generally good.